Idera Pharmaceuticals, Inc.
(NASDAQ : IDRA)

( )
IDRA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -0.36%344.500.0%$4293.79m
BNTXBioNTech SE 1.74%297.480.0%$826.24m
NVAXNovavax, Inc. -0.81%133.9079.4%$752.66m
AMGNAmgen, Inc. 0.00%208.681.4%$526.19m
REGNRegeneron Pharmaceuticals, Inc. 0.00%592.152.7%$478.99m
SNSSSunesis Pharmaceuticals, Inc. 0.00%6.210.7%$434.10m
GILDGilead Sciences, Inc. -0.66%67.281.0%$395.23m
CCXIChemoCentryx, Inc. -0.83%33.442.9%$383.29m
ILMNIllumina, Inc. 0.00%417.193.3%$357.19m
XLRNAcceleron Pharma, Inc. 0.00%173.785.3%$335.39m
OCGNOcugen, Inc. -0.55%9.100.0%$301.69m
VRTXVertex Pharmaceuticals, Inc. 0.23%184.501.9%$274.69m
BIIBBiogen, Inc. 0.00%271.121.8%$271.81m
XENEXenon Pharmaceuticals, Inc. 0.00%30.570.4%$164.85m
CRSPCRISPR Therapeutics AG 0.06%95.120.6%$159.17m

Company Profile

Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.